Forward Citations = 13

Loading Chart...

6 inventors (with patents filed for the assignee):

Pierre Langlade Demoyen (7 out of 17 patents)

Maria Loustau (7 out of 7 patents)

Julien Caumartin (7 out of 8 patents)

4. François Anna (4 out of 4 patents)

5. Thierry Huet (3 out of 6 patents)

6. Maria Wehbe (3 out of 3 patents)

7 patents: Sort by Forward Citations

1. 12297275 - Chimeric antigen receptors against multiple HLA-G isoforms (2025-05-13),

2. 11634494 - Anti HLA-G specific antibodies (2023-04-25),

3. 11505608 - Chimeric antigen receptors against multiple HLA-G isoforms (2022-11-22),

4. 11325977 - Chimeric antigen receptors against multiple HLA-G isoforms (2022-05-10),

5. 11312774 - Anti HLA-G specific antibodies (2022-04-26),

6. 11117971 - Chimeric antigen receptors against multiple HLA-G isoforms (2021-09-14),

7. 11111302 - Anti HLA-G specific antibodies (2021-09-07),

Invectys Sa is a biotechnology company specialized in developing innovative cancer immunotherapies. Their proprietary technology targets tumor cells and stimulates the immune system to fight against cancer. With a focus on precision medicine, Invectys Sa aims to provide personalized treatment options for patients with various types of cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#451 in Paris

#2,217 in France

Paris, France

Invectys Sa